Arizona State Retirement System Trims Boeing Stake While Increasing Pharma Holdings

The Arizona State Retirement System held 207,154 Boeing shares after selling 7,431 shares during the quarter. Deutsche Bank was among the notable institutional investors increasing its Boeing position, adding 765,197 shares to reach 2,376,243 shares.
California State Teachers Retirement System made a particularly large move in Merck, adding 480,884,635 shares during the second quarter and bringing its total holding to 484,720,247 shares, according to the filing.
BlackRock increased its Bristol Myers Squibb position by 8,702,106 shares in the second quarter, reaching 180,384,994 shares valued at about $10.39 billion. The article also reported that Bristol Myers Squibb senior vice president Phil M. Holzer sold 500 shares on Aug. 25.
In Amgen-related trading, senior vice president Nancy Grygiel sold 2,970 shares on Aug. 6 at an average price of $402.10. The filing also identified Nykredit A/S as a new institutional investor with a position valued at approximately $48.97 million.
Philip Morris International shares were trading at $184.94 in the article’s cited Tuesday session, with a market capitalization of approximately $288.25 billion, a price-to-earnings ratio of 26.57 and a 52-week range of $142.11 to $207.76.
Arizona State Retirement System made small moves across five major companies in the second quarter, according to SEC filings. The pension fund trimmed its Boeing position by 3.5% while boosting stakes in Merck, Bristol Myers Squibb, Amgen, and Philip Morris International by roughly 0.9% to 1.6% each. These five holdings were valued at a combined $298 million.
The adjustments reveal a shift toward pharmaceuticals and consumer health. Large institutional investors and hedge funds control over 64% of shares in each company. Major players like BlackRock and California State Teachers Retirement System made much bigger moves, signaling confidence in these sectors despite broader market uncertainty.
Arizona State Retirement System sold 7,431 Boeing shares in the quarter, cutting its position to 207,154 shares worth $44.8 million according to SEC filings. The move contrasts with other major investors. Deutsche Bank added 765,197 Boeing shares, reaching 2.4 million shares total. The pension fund's retreat signals caution about the aerospace manufacturer.
On the flip side, Arizona boosted holdings in four health companies. Merck got $88.2 million in funding through a 0.9% stake increase. Bristol Myers Squibb rose to $32.6 million and Amgen to $54.2 million. Philip Morris International climbed to $78.2 million. These moves suggest the fund is betting on stable earnings from established pharma names.
California State Teachers Retirement System executed a blockbuster trade in Merck during the quarter per SEC filings. The fund added 480.9 million shares, bringing its total position to 484.7 million shares. This enormous purchase dwarfs most other institutional moves and suggests deep confidence in Merck's dividend and pipeline. The timing puts CalSTRS among Merck's largest shareholders.
BlackRock increased its Bristol Myers Squibb stake by 8.7 million shares during the quarter according to SEC filings, reaching 180.4 million shares. The position is now valued at about $10.39 billion. Company insiders showed mixed signals — senior vice president Phil M. Holzer sold just 500 shares on August 25. BlackRock's aggressive buying suggests the index giant expects the biopharma company to outperform.
Philip Morris International shares traded at $184.94 on the filing date per SEC filings, giving the tobacco company a $288.25 billion market cap. The stock trades at 26.57 times earnings. Its 52-week range spans $142.11 to $207.76, showing solid momentum. Amgen, meanwhile, attracted a new institutional backer — Nykredit A/S — which built a $48.97 million position.
Publishers
15
Articles
9
Reach
24